John B. Sanfilippo & SON (JBSS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Aug 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the JBSS SEC filings page.
John B. Sanfilippo & SON (JBSS) reported $1.2B in revenue for fiscal year 2026, up 6.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Sales have expanded, but thinner margins and heavier reinvestment make cash generation more uneven than reported earnings suggest.
Gross margin declined from21.6% in FY2021 to18.0% in FY2026; operating margin compression confirms that sales growth did not translate into proportionally more operating profit.
FY2025 paired operating cash flow of
Inventory rose from
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of John B. Sanfilippo & SON's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
John B. Sanfilippo & SON has an operating margin of 7.6%, meaning the company retains $8 of operating profit per $100 of revenue. This strong profitability earns a score of 71/100, reflecting efficient cost management and pricing power. This is unchanged from the prior year.
John B. Sanfilippo & SON's revenue grew 6.2% year-over-year to $1.2B, a solid pace of expansion. This earns a growth score of 50/100.
John B. Sanfilippo & SON carries a low D/E ratio of 0.11, meaning only $0.11 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 66/100, indicating a strong balance sheet with room for future borrowing.
John B. Sanfilippo & SON's current ratio of 2.08 indicates adequate short-term liquidity, earning a score of 61/100. The company can meet its near-term obligations, though with limited headroom.
John B. Sanfilippo & SON has a free cash flow margin of 3.0%, earning a moderate score of 34/100. The company generates positive cash flow after capital investments, but with room for improvement.
John B. Sanfilippo & SON earns a strong 16.3% return on equity (ROE), meaning it generates $16 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 87/100. This is unchanged from the prior year.
John B. Sanfilippo & SON scores 4.79, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
John B. Sanfilippo & SON passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, John B. Sanfilippo & SON generates $2.00 in operating cash flow ($123.8M OCF vs $61.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
John B. Sanfilippo & SON earns $36.72 in operating income for every $1 of interest expense ($89.2M vs $2.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
John B. Sanfilippo & SON generated $280.4M in revenue in Q4 2026. This represents an increase of 4.2% from the same quarter a year earlier. Against the prior quarter it is down 0.5%.
John B. Sanfilippo & SON's EBITDA was $19.9M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 28.5% from the same quarter a year earlier. Against the prior quarter it is down 34.9%.
John B. Sanfilippo & SON reported $8.4M in net income in Q4 2026. This represents a decrease of 37.9% from the same quarter a year earlier. Against the prior quarter it is down 50.1%.
John B. Sanfilippo & SON earned $0.71 per diluted share (EPS) in Q4 2026. This represents a decrease of 38.8% from the same quarter a year earlier. Against the prior quarter it is down 50.3%.
Cash & Balance Sheet
John B. Sanfilippo & SON generated $9.9M in free cash flow in Q4 2026, representing cash available after capex. This represents a decrease of 57.0% from the same quarter a year earlier. Against the prior quarter it is up 146.2%.
John B. Sanfilippo & SON held $1.1M in cash against $43.6M in long-term debt as of Q4 2026.
Not reported for Q4 2026.
Margins & Returns
John B. Sanfilippo & SON's gross margin was 15.7% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is down 2.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.3 percentage points.
John B. Sanfilippo & SON's operating margin was 4.4% in Q4 2026, reflecting core business profitability. This is down 3.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.0 percentage points.
John B. Sanfilippo & SON's net profit margin was 3.0% in Q4 2026, showing the share of revenue converted to profit. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.0 percentage points.
John B. Sanfilippo & SON's ROE was 2.2% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is down 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.1 percentage points.
Capital Allocation
John B. Sanfilippo & SON invested $19.1M in capex in Q4 2026, funding long-term assets and infrastructure. This represents an increase of 41.6% from the same quarter a year earlier. Against the prior quarter it is down 11.8%.
Not reported for Q4 2026.
Not reported for Q4 2026.
JBSS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $280.4M+4.2% | $281.8M+8.0% | $314.8M+4.6% | $298.7M+8.1% | $269.1M-0.2% | $260.9M-4.0% | $301.1M+3.4% | $276.2M+18.0% |
| Cost of Revenue | $236.3M+7.3% | $228.0M+11.2% | $255.6M+2.7% | $244.6M+6.5% | $220.3M+0.3% | $205.0M-7.9% | $248.8M+6.7% | $229.7M+29.7% |
| Gross Profit | $44.1M-9.5% | $53.8M-3.8% | $59.2M+13.2% | $54.1M+16.2% | $48.8M-2.4% | $55.9M+13.7% | $52.3M-9.8% | $46.5M-18.4% |
| SG&A Expenses | $11.1M+2.5% | $10.7M+18.3% | $12.1M+17.4% | $9.2M-5.2% | $10.8M-24.5% | $9.1M-25.5% | $10.3M-11.3% | $9.7M-7.2% |
| Operating Income | $12.4M-38.3% | $23.8M-15.6% | $26.0M+34.1% | $27.0M+58.9% | $20.1M+37.4% | $28.2M+53.6% | $19.4M-29.8% | $17.0M-30.8% |
| EBITDA | $19.9M-28.5% | $30.6M-11.6% | $32.7M+27.7% | $34.2M+45.1% | $27.9M+31.6% | $34.6M+40.2% | $25.6M-24.9% | $23.6M-21.0% |
| Interest Expense | $419K-65.3% | $523K-50.4% | $503K-34.8% | $984K+90.7% | $1.2M+150.8% | $1.1M+34.4% | $772K-26.8% | $516K+127.3% |
| Income Tax | $2.7M-41.2% | $5.4M-9.0% | $6.6M+52.6% | $6.3M+56.2% | $4.6M+32.9% | $6.0M+75.3% | $4.3M-36.5% | $4.1M-33.0% |
| Net Income | $8.4M-37.9% | $16.8M-16.4% | $18.0M+32.1% | $18.7M+60.6% | $13.5M+35.1% | $20.2M+49.5% | $13.6M-29.1% | $11.7M-33.7% |
| EPS (Basic) | $0.71-38.8% | $1.44-16.8% | $1.54+31.6% | $1.60+60.0% | $1.16+34.9% | $1.73+49.1% | $1.17-29.1% | $1.00-34.2% |
| EPS (Diluted) | $0.71-38.8% | $1.43-16.9% | $1.53+31.9% | $1.59+59.0% | $1.16+36.5% | $1.72+49.6% | $1.16-29.3% | $1.00-33.8% |
| Diluted Shares (Avg) | N/A | 12M+0.5% | 12M+0.3% | 12M+0.3% | N/A | 12M+0.3% | 12M+0.4% | 12M+0.3% |
Not reported in any period shown, so not listed: R&D Expenses.
JBSS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $658.6M+10.2% | $650.7M+10.3% | $617.7M+13.3% | $598.7M+15.3% | $597.6M+15.9% | $590.0M+19.9% | $545.3M+12.5% | $519.4M+22.2% |
| Current Assets | $349.3M+0.8% | $352.1M+0.8% | $337.2M+10.0% | $333.5M+16.0% | $346.4M+17.8% | $349.2M+17.8% | $306.7M+5.8% | $287.5M+14.3% |
| Cash & Equivalents | $1.1M+96.1% | $1.3M-0.3% | $2.4M+614.3% | $714K+61.5% | $585K+20.9% | $1.3M+243.5% | $336K-83.0% | $442K-47.3% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $245.8M-3.4% | $252.6M-2.0% | $235.4M+14.4% | $234.7M+20.6% | $254.6M+29.5% | $257.8M+22.4% | $205.8M+4.3% | $194.6M+11.3% |
| Accounts Receivable | $84.3M+10.0% | $85.2M+14.4% | $79.8M-1.7% | $84.4M+0.7% | $76.7M-9.8% | $74.5M-1.5% | $81.2M+4.9% | $83.8M+22.6% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% |
| Total Liabilities | $278.6M+17.6% | $263.0M+8.1% | $247.6M+12.7% | $235.9M+13.1% | $236.9M+22.8% | $243.4M+43.1% | $219.6M+23.9% | $208.6M+51.7% |
| Current Liabilities | $167.9M+7.6% | $153.2M-12.0% | $148.4M-1.1% | $136.7M-2.3% | $156.0M+23.9% | $174.0M+44.5% | $150.1M+17.0% | $139.8M+56.6% |
| Non-Current Liabilities | $110.7M+36.9% | $109.8M+58.3% | $99.2M+42.6% | $99.2M+44.4% | $80.9M+20.6% | $69.4M+39.5% | $69.6M+42.2% | $68.7M+42.6% |
| Long-Term Debt | $43.6M+199.1% | $40.7M+605.5% | $28.8M+383.1% | $29.8M+383.5% | $14.6M+128.8% | $5.8M-12.1% | $6.0M-11.5% | $6.2M-10.9% |
| Total Equity | $379.9M+5.3% | $387.6M+11.8% | $370.1M+13.7% | $362.8M+16.7% | $360.7M+11.8% | $346.6M+7.7% | $325.6M+6.0% | $310.8M+8.2% |
| Retained Earnings | $236.7M+6.9% | $245.8M+18.2% | $229.0M+21.9% | $222.7M+27.8% | $221.5M+18.5% | $208.0M+10.3% | $187.8M+7.3% | $174.2M+11.7% |
JBSS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $29.0M-20.6% | $197K+100.8% | $62.5M+469.0% | $32.1M+259.7% | $36.5M+3.7% | -$25.9M-591.9% | $11.0M-72.0% | $8.9M-59.2% |
| Depreciation & Amortization | $7.0M-0.7% | $6.8M+6.2% | $6.7M+7.9% | $7.2M+9.3% | $7.0M+7.8% | $6.4M+1.4% | $6.2M-3.9% | $6.5M+25.0% |
| Stock-Based Compensation | N/A | $708K-15.2% | $1K-14.3% | $854K-8.7% | N/A | $835K-24.0% | $2K-99.9% | $935K+25.2% |
| Capital Expenditures | $19.1M+41.6% | $21.7M+85.5% | $22.4M+64.5% | $24.9M+109.1% | $13.5M+24.4% | $11.7M+77.3% | $13.6M+179.2% | $11.9M+98.6% |
| Free Cash Flow | $9.9M-57.0% | -$21.5M+42.9% | $40.0M+1602.1% | $7.3M+344.6% | $23.0M-5.5% | -$37.6M-2747.0% | -$2.7M-107.7% | -$3.0M-118.7% |
| Investing Cash Flow | -$18.7M-38.7% | -$21.2M-81.0% | -$21.3M-56.1% | -$24.9M-108.5% | -$13.5M-24.2% | -$11.7M-78.0% | -$13.7M+78.6% | -$12.0M-97.8% |
| Financing Cash Flow | -$10.5M+55.9% | $19.9M-48.4% | -$39.5M-1633.6% | -$7.1M-337.3% | -$23.8M+2.1% | $38.6M+13979.1% | $2.6M-90.0% | $3.0M+117.6% |
| Dividends Paid | $17.6M | $11.7M | $0 | $17.5M-28.3% | $0-100.0% | $0 | $0 | $24.4M+5.3% |
Not reported in any period shown, so not listed: Share Buybacks.
JBSS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 15.7%-2.4pp | 19.1%-2.3pp | 18.8%+1.4pp | 18.1%+1.3pp | 18.1%-0.4pp | 21.4%+3.3pp | 17.4%-2.5pp | 16.9%-7.5pp |
| Operating Margin | 4.4%-3.1pp | 8.4%-2.4pp | 8.3%+1.8pp | 9.0%+2.9pp | 7.5%+2.0pp | 10.8%+4.1pp | 6.4%-3.0pp | 6.2%-4.3pp |
| Net Margin | 3.0%-2.0pp | 6.0%-1.7pp | 5.7%+1.2pp | 6.3%+2.1pp | 5.0%+1.3pp | 7.7%+2.8pp | 4.5%-2.1pp | 4.2%-3.3pp |
| Return on Equity | 2.2%-1.5pp | 4.3%-1.5pp | 4.9%+0.7pp | 5.2%+1.4pp | 3.8%+0.6pp | 5.8%+1.6pp | 4.2%-2.1pp | 3.8%-2.4pp |
| Return on Assets | 1.3%-1.0pp | 2.6%-0.8pp | 2.9%+0.4pp | 3.1%+0.9pp | 2.3%+0.3pp | 3.4%+0.7pp | 2.5%-1.5pp | 2.2%-1.9pp |
| Current Ratio | 2.08-0.1x | 2.30+0.3x | 2.27+0.2x | 2.44+0.4x | 2.22-0.1x | 2.01-0.5x | 2.04-0.2x | 2.06-0.8x |
| Debt-to-Equity | 0.11+0.1x | 0.10+0.1x | 0.08+0.1x | 0.08+0.1x | 0.040.0x | 0.020.0x | 0.020.0x | 0.020.0x |
| Asset Turnover | 0.430.0x | 0.430.0x | 0.510.0x | 0.500.0x | 0.45-0.1x | 0.44-0.1x | 0.550.0x | 0.530.0x |
| FCF Margin | 3.5%-5.0pp | -7.6%+6.8pp | 12.7%+13.6pp | 2.4%+3.5pp | 8.6%-0.5pp | -14.4%-13.9pp | -0.9%-12.7pp | -1.1%-7.9pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| John B. Sanfilippo & SON JBSS | FY2026 | $1.2B | $61.9M | 5.3% | $801.2M | 62/100 |
| Seneca Foods Corp SENEB | FY2026 | N/A | $114.7M | N/A | $1.2B | — |
| Seneca Foods Corp SENEA | FY2026 | N/A | $114.7M | N/A | $1.2B | — |
| Treehouse Foods, Inc. THS | FY2024 | $3.4B | $26.9M | 0.8% | $1.2B | 29/100 |
| Utz Brands, Inc. UTZ | FY2025 | $1.4B | $800K | 0.1% | $1.3B | 29/100 |
| Herbalife Ltd. HLF | FY2025 | $5.0B | $228.3M | 4.5% | $1.3B | 46/100 |
Where John B. Sanfilippo & SON Ranks
Frequently Asked Questions
What is John B. Sanfilippo & SON's annual revenue?
John B. Sanfilippo & SON (JBSS) reported $1.2B in total revenue for fiscal year 2026. This represents a 6.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is John B. Sanfilippo & SON's revenue growing?
John B. Sanfilippo & SON (JBSS) revenue grew by 6.2% year-over-year, from $1.1B to $1.2B in fiscal year 2026.
Is John B. Sanfilippo & SON profitable?
Yes, John B. Sanfilippo & SON (JBSS) reported a net income of $61.9M in fiscal year 2026, with a net profit margin of 5.3%.
What is John B. Sanfilippo & SON's EBITDA?
John B. Sanfilippo & SON (JBSS) had EBITDA of $117.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does John B. Sanfilippo & SON have?
As of fiscal year 2026, John B. Sanfilippo & SON (JBSS) had $1.1M in cash and equivalents against $43.6M in long-term debt.
What is John B. Sanfilippo & SON's gross margin?
John B. Sanfilippo & SON (JBSS) had a gross margin of 18.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is John B. Sanfilippo & SON's operating margin?
John B. Sanfilippo & SON (JBSS) had an operating margin of 7.6% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is John B. Sanfilippo & SON's net profit margin?
John B. Sanfilippo & SON (JBSS) had a net profit margin of 5.3% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Does John B. Sanfilippo & SON pay dividends?
Yes, John B. Sanfilippo & SON (JBSS) paid $4.00 per share in dividends during fiscal year 2026.
What is John B. Sanfilippo & SON's return on equity (ROE)?
John B. Sanfilippo & SON (JBSS) has a return on equity of 16.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is John B. Sanfilippo & SON's free cash flow?
John B. Sanfilippo & SON (JBSS) generated $35.7M in free cash flow during fiscal year 2026. This represents a 277.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is John B. Sanfilippo & SON's operating cash flow?
John B. Sanfilippo & SON (JBSS) generated $123.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are John B. Sanfilippo & SON's total assets?
John B. Sanfilippo & SON (JBSS) had $658.6M in total assets as of fiscal year 2026, including both current and long-term assets.
What are John B. Sanfilippo & SON's capital expenditures?
John B. Sanfilippo & SON (JBSS) invested $88.1M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does John B. Sanfilippo & SON spend on research and development?
John B. Sanfilippo & SON (JBSS) invested $3.3M in research and development during fiscal year 2026.
What is John B. Sanfilippo & SON's current ratio?
John B. Sanfilippo & SON (JBSS) had a current ratio of 2.08 as of fiscal year 2026, which is generally considered healthy.
What is John B. Sanfilippo & SON's debt-to-equity ratio?
John B. Sanfilippo & SON (JBSS) had a debt-to-equity ratio of 0.11 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is John B. Sanfilippo & SON's return on assets (ROA)?
John B. Sanfilippo & SON (JBSS) had a return on assets of 9.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is John B. Sanfilippo & SON's P/E ratio?
John B. Sanfilippo & SON (JBSS) trades at 12.9x earnings, its market capitalization divided by net income of $61.9M net income, FY2026. The market capitalization is $801.2M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is John B. Sanfilippo & SON's price-to-sales ratio?
John B. Sanfilippo & SON (JBSS) trades at 0.7x sales, its market capitalization divided by revenue of $1.2B revenue, FY2026. The market capitalization is $801.2M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is John B. Sanfilippo & SON's Altman Z-Score?
John B. Sanfilippo & SON (JBSS) has an Altman Z-Score of 4.79, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is John B. Sanfilippo & SON's Piotroski F-Score?
John B. Sanfilippo & SON (JBSS) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are John B. Sanfilippo & SON's earnings high quality?
John B. Sanfilippo & SON (JBSS) has an earnings quality ratio of 2.00x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can John B. Sanfilippo & SON cover its interest payments?
John B. Sanfilippo & SON (JBSS) has an interest coverage ratio of 36.72x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is John B. Sanfilippo & SON?
John B. Sanfilippo & SON (JBSS) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.